Sanofi India Limited is a leading pharmaceutical company in India, engaged in manufacturing and trading drugs and pharmaceuticals. It has a strong presence in the diabetes market, particularly with its insulin products like Lantus and Toujeo.

Sanofi India has undergone a significant business model transformation, focusing on digital empowerment and strategic partnerships to strengthen its leadership in the insulin market, demonstrating strong growth potential.

The company has leveraged AI extensively across its operations to optimize efficiencies and enhance growth prospects, particularly in its sales and commercialization processes.

Through strategic partnerships, Sanofi India has expanded its reach, particularly in emerging markets and smaller Indian cities, ensuring sustained growth and market penetration beyond Tier 1 cities.

Despite a reduction in export revenues due to previous site divestments, Sanofi India has mitigated bottom-line impacts through domestic revenue growth and focus on high-margin insulin products.